沃达利单抗
Anti-Human PD-1xCTLA-4 Bispecific Antibody(Vudalimab;XmAb-20717,cytotoxic T-lymphocyte-associated protein 4, CD152;programmed cell death 1, PD1, PD-1, CD279)
ChemLeader
产品编号:
CAS No.:
MDLNo:
分子式:
分子量:
选择规格
选择数量
- +
基本信息
中文名称沃达利单抗
英文名称 Anti-Human PD-1xCTLA-4 Bispecific Antibody(Vudalimab;XmAb-20717,cytotoxic T-lymphocyte-associated protein 4, CD152;programmed cell death 1, PD1, PD-1, CD279)
CAS号2329669-72-7
储存条件 Avoid repeated freeze-thaw. -80°C for one-year storage.
安全信息
产品详情

Vudalimab is a fully humanized bispecific antibody that potently inhibits both PD-1 and CTLA-4, key immune checkpoint receptors. It is designed to selectively activate tumor-targeting T cells, enhancing the immune response against cancer.

相关产品
抱歉,暂时没有相关产品
浏览记录
N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2-[(2-氟-4-碘苯)氨基]苯甲酰胺
托萨托舒单抗
沃达利单抗
ST-836
(R)-6-(2-(乙基(4-(2-(乙基氨基)乙基)苄基)氨基)-4-甲氧基苯基)-5,6,7,8-四氢萘-2-醇;艾拉司群
5-羟基-4-甲氧基-6H-吲哚并[3,2,1-de][1,5]萘啶-6-酮 ; 苦木酮;苦木酮碱;苦木碱己
竹桃霉素
络缌 | 松香树脂
N-[[(5S)-3-[2-氟-4-[[(1H-1,2,3-三唑-5-基甲基)氨基]甲基][1,1-联苯]-4-基]-2-氧代-5-恶唑啉基]甲基]乙酰胺; 雷得唑来
8-环戊基-1,3-二丙基-1H-嘌呤-2,6(3H,7H)-二酮 ; 1,3-二丙基-8-环戊基黄嘌呤